UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Pharmacokinetics, Safety, and Efficacy of Trastuzumab Administered Every Three Weeks in Combination With Paclitaxel

Journal of clinical oncology, 2003-11, Vol.21 (21), p.3965-3971

2003

Volltextzugriff (PDF)

Maintaining Normal Hemoglobin Levels With Epoetin Alfa in Mainly Nonanemic Patients With Metastatic Breast Cancer Receiving First-Line Chemotherapy: A Survival Study

Journal of clinical oncology, 2005-09, Vol.23 (25), p.5960-5972

2005

Volltextzugriff (PDF)

Hypersensitivity reactions from taxol

Journal of clinical oncology, 1990-07, Vol.8 (7), p.1263-1268

1990

Volltextzugriff (PDF)

The systemic administration of intravenous melphalan

Journal of clinical oncology, 1988-11, Vol.6 (11), p.1768-1782

1988

Volltextzugriff (PDF)

Fludarabine phosphate: a synthetic purine antimetabolite with significant activity against lymphoid malignancies

Journal of clinical oncology, 1991-01, Vol.9 (1), p.175-188

1991

Volltextzugriff (PDF)

Hypersensitivity reactions to teniposide (VM-26): an analysis

Journal of clinical oncology, 1986-08, Vol.4 (8), p.1262-1269

1986

Volltextzugriff (PDF)

N-methylformamide: cytotoxic, radiosensitizer, or chemosensitizer

Journal of clinical oncology, 1988-05, Vol.6 (5), p.906-918

1988

Volltextzugriff (PDF)

Teniposide in the treatment of leukemia: a case study of conflicting priorities in the development of drugs for fatal diseases

Journal of clinical oncology, 1988-02, Vol.6 (2), p.351-379

1988

Volltextzugriff (PDF)

A phase II study of lonafarnib (LF) in patients with locally advanced and metastatic breast cancer (MBC): Hoosier Oncology Group BRE07-126

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.598-598

2011

Volltextzugriff (PDF)

Evaluation of the effect of calpain inhibitor AK295 on paclitaxel-induced neuropathy and antitumor activity in human cancer xenograft models

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.e13510-e13510

2010

Volltextzugriff (PDF)

Acivicin: a new glutamine antagonist in clinical trials

Journal of clinical oncology, 1984-09, Vol.2 (9), p.1064-1071

1984

Volltextzugriff (PDF)

High pathologic complete response (pCR) in HER2-positive breast cancer to novel nonanthracycline neoadjuvant chemotherapy

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.625-625

2010

Volltextzugriff (PDF)

ESR1 and ESR2 polymorphisms in BIG 1−98 comparing adjuvant letrozole (L) versus tamoxifen (T) or their sequence for early breast cancer

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.1002-1002

2011

Volltextzugriff (PDF)

An open-label study of sunitinib (SU) plus exemestane (E) in the first-line treatment of hormone receptor (HR)-positive metastatic breast cancer (MBC)

Journal of clinical oncology, 2009-05, Vol.27 (15_suppl), p.e12019-e12019

2009

Volltextzugriff (PDF)

Thymidilate synthase gene copy number as predictive marker of capecitabine efficacy in patients with breast cancer

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.10629-10629

2011

Volltextzugriff (PDF)

Discovery of a novel set of prostate cancer-related genes associated with the prognostically important TMPRSS2:ERG fusion gene

Journal of clinical oncology, 2008-05, Vol.26 (15_suppl), p.5056-5056

2008

Volltextzugriff (PDF)

Thymidilate synthase (TS), thymidine phosphorylase (TP), dihydropyrimidine dehydrogenase (DPD), and dihydrofolate reductase (DHFR) as predictive markers of capecitabine efficacy in breast cancer patients

Journal of clinical oncology, 2009-05, Vol.27 (15_suppl), p.11033-11033

2009

Volltextzugriff (PDF)

Homoharringtonine--perspectives on an active new natural product

Journal of clinical oncology, 1986-10, Vol.4 (10), p.1563-1568

1986

Volltextzugriff (PDF)

Anthracyclines vs taxanes plus trastuzumab in HER2-positive metastatic breast cancer (MBC): A cross trial comparison of pivotal studies

Journal of clinical oncology, 2005-06, Vol.23 (16_suppl), p.743-743

2005

Volltextzugriff (PDF)

A novel loading regimen for trastuzumab in MBC: Boost serum levels in early cycles

Journal of clinical oncology, 2005-06, Vol.23 (16_suppl), p.594-594

2005

Volltextzugriff (PDF)

Effects of trastuzumab (H) and chemotherapy on circulating HER2 extracellular domain (ECD) in patients with metastatic breast cancer (MBC) and non-small cell lung cancer (NSCLC)

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.570-570

2004

Volltextzugriff (PDF)

Effects of trastuzumab (H) and chemotherapy on circulating HER2 extracellular domain (ECD) in patients with metastatic breast cancer (MBC) and non-small cell lung cancer (NSCLC)

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.570-570

2004

Volltextzugriff (PDF)

Dichloromethotrexate--a critical reassessment

Journal of clinical oncology, 1985-08, Vol.3 (8), p.1148-1153

1985

Volltextzugriff (PDF)

Randomized phase III study of trastuzumab, paclitaxel, and carboplatin versus trastuzumab and paclitaxel in women with HER-2 overexpressing metastatic breast cancer: An update including survival

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.573-573

2004

Volltextzugriff (PDF)

Clinical benefit of trastuzumab (H) among patients with HER2-positive metastatic breast cancer (MBC) not achieving objective responses when treated with H plus chemotherapy (CT)

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.680-680

2004

Volltextzugriff (PDF)

1 – 25 von 43

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieJournal Of Clinical Oncology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(43)
Mit Volltextzugriff
(43)

Publikationsform

Artikel
(43)

Sprache

Englisch
(43)

Erscheinungsjahr

n.n

Thema

Humans
(13)
Life Sciences & Biomedicine
(13)
Oncology
(13)
Science & Technology
(13)
Aged
(5)
Drug Evaluation
(5)
Female
(5)
Middle Aged
(5)
Adult
(4)
Animals
(4)
Breast Neoplasms - Pathology
(4)
Neoplasms - Drug Therapy
(4)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(3)
Breast Neoplasms - Drug Therapy
(3)
Drug Administration Schedule
(3)
Drug Evaluation, Preclinical
(3)
Kinetics
(3)
Leukemia - Drug Therapy
(3)
Male
(3)
Antineoplastic Agents - Therapeutic Use
(2)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

1 weiteren anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

J Clin Oncol
(1)

Menü

Weitere Dienste

Einstellungen

Pharmacokinetics, Safety, and Efficacy of Trastuzumab Administered Every Three Weeks in Combination With Paclitaxel

Maintaining Normal Hemoglobin Levels With Epoetin Alfa in Mainly Nonanemic Patients With Metastatic Breast Cancer Receiving First-Line Chemotherapy: A Survival Study

Hypersensitivity reactions from taxol

The systemic administration of intravenous melphalan

Fludarabine phosphate: a synthetic purine antimetabolite with significant activity against lymphoid malignancies

Hypersensitivity reactions to teniposide (VM-26): an analysis

N-methylformamide: cytotoxic, radiosensitizer, or chemosensitizer

Teniposide in the treatment of leukemia: a case study of conflicting priorities in the development of drugs for fatal diseases

A phase II study of lonafarnib (LF) in patients with locally advanced and metastatic breast cancer (MBC): Hoosier Oncology Group BRE07-126

Evaluation of the effect of calpain inhibitor AK295 on paclitaxel-induced neuropathy and antitumor activity in human cancer xenograft models

Acivicin: a new glutamine antagonist in clinical trials

High pathologic complete response (pCR) in HER2-positive breast cancer to novel nonanthracycline neoadjuvant chemotherapy

ESR1 and ESR2 polymorphisms in BIG 1−98 comparing adjuvant letrozole (L) versus tamoxifen (T) or their sequence for early breast cancer

An open-label study of sunitinib (SU) plus exemestane (E) in the first-line treatment of hormone receptor (HR)-positive metastatic breast cancer (MBC)

Thymidilate synthase gene copy number as predictive marker of capecitabine efficacy in patients with breast cancer

Discovery of a novel set of prostate cancer-related genes associated with the prognostically important TMPRSS2:ERG fusion gene

Thymidilate synthase (TS), thymidine phosphorylase (TP), dihydropyrimidine dehydrogenase (DPD), and dihydrofolate reductase (DHFR) as predictive markers of capecitabine efficacy in breast cancer patients

Homoharringtonine--perspectives on an active new natural product

Anthracyclines vs taxanes plus trastuzumab in HER2-positive metastatic breast cancer (MBC): A cross trial comparison of pivotal studies

A novel loading regimen for trastuzumab in MBC: Boost serum levels in early cycles

Effects of trastuzumab (H) and chemotherapy on circulating HER2 extracellular domain (ECD) in patients with metastatic breast cancer (MBC) and non-small cell lung cancer (NSCLC)

Effects of trastuzumab (H) and chemotherapy on circulating HER2 extracellular domain (ECD) in patients with metastatic breast cancer (MBC) and non-small cell lung cancer (NSCLC)

Dichloromethotrexate--a critical reassessment

Randomized phase III study of trastuzumab, paclitaxel, and carboplatin versus trastuzumab and paclitaxel in women with HER-2 overexpressing metastatic breast cancer: An update including survival

Clinical benefit of trastuzumab (H) among patients with HER2-positive metastatic breast cancer (MBC) not achieving objective responses when treated with H plus chemotherapy (CT)

Aktive Filter

Suchergebnisse filtern